Dice CEO: Energy, T...
Health Care: Drugs
BioMarin Pharmaceuticals Inc (BMRN: NASDAQ)
$35.53 -0.11 | -0.31%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 35.53 |
| 52 Week High | 39.29 |
| 52 Week Low | 23.74 |
| Avg. Daily Vol. (Mil) | 1.14 |
| Beta (3 year) | 0.76 |
| Share Related Items | |
| Mkt Cap (Mil) | 4,110.86 |
| Shares Out (Mil) | 115.70 |
| Float (Mil) | 86.09 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.80 |
| Current Ratio | 4.30 |
| LT Debt/ Equity | 0.42 |
| Total Debt / Equity | 0.45 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 9.16 |
| Price/Book | 5.33 |
| Price/Cash Flow | -130.00 |
| Per Share Data | |
| Earnings | -0.66 |
| Sales | 3.88 |
| Book Value | 6.67 |
| Cash Flow | -0.27 |
| Business Summary | |
|---|---|
| Biomarin Pharmaceutical, Inc., develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its Approved products include Naglazyme, Kuvan tablets, Aldurazyme and Firdapse. | |
| General Information | |
| 105 Digital Drive
Novato, CA 94949 |
|
| www.biomarinpharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1002 | |
| CEO: Jean-Jacques Bienaime | |
| Short Interest | |
| Current Month (Mil) | 11.94 |
| Previous Month (Mil) | 11.08 |
| Short Interest Ratio (Days) | 10.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -5.70 |
| Return on Investments | -6.70 |
| Profitability | |
| Gross Margin | 91.40 |
| EBIT Margin | -13.30 |
| Profit Margin | -16.40 |
Portfolios with BMRN
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- UserScottrade IRA
- UserEverett Bishop Portfolio 1
- ContributorEarnings Short Squeeze Play...
- Userwjwallace Portfolio
- ContributorStocks At New 52-Week Highs...
- ProColumbia Wanger Asset Manag...
- Contributor21 Stocks to Watch
- ContributorBreakout Stocks Of The Week...
Latest BMRN Headlines from TheStreet
- BioMarin Stock Falls On Unusually High Volume (BMRN) 05.31.12 | 02:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.29.12 | 10:05 am
- 8 Stocks Rising on Big Volume 05.21.12 | 01:05 pm
- 5 Stocks Hit 52-Week Highs 05.16.12 | 01:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.16.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- BioMarin Pharmaceutical's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.27.12 | 03:04 am
- BioMarin Pharmaceutical's CEO Discusses Q4 2011 Earning Results - Earnings Call Transcript 02.16.12 | 11:02 pm
- 5 Earnings Stocks Poised to Pop 02.16.12 | 12:02 pm
- BIO CEO Confab Live Blog: Day 2 02.14.12 | 10:02 am
Press Releases for BMRN
- IU Confidential Publishes Biotech Investment Report - PR Newswire 07.28.11 | 09:07 am
- BioMarin Launches Firdapse In The European Union - PR Newswire 04.19.10 | 09:04 am
- BioMarin To Present At The Barclays Capital Global Healthcare Conference - PR Newswire 03.17.10 | 09:03 am
- BioMarin To Acquire LEAD Therapeutics - PR Newswire 02.04.10 | 04:02 pm
Partner Headlines for BMRN
- BioMarin Prices Share Offering - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Analyst Insights: Finish Line, BioMarin Pharma, Laboratory Corp, Ocz Technology, AstraZeneca May 31st - Wall St. Cheat Sheet 05.31.12 | 10:05 am
- 9 High-Liquidity Mid Caps Poised For Growth - Seeking Alpha 05.28.12 | 08:05 am
- Loss at BioMarin Wider Than Expected - Analyst Blog - Zacks 02.17.12 | 09:02 am
- Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone and United Parcel Services - Press Releases - Zacks 02.14.12 | 09:02 am
- BioMarin Pharmaceutical (BMRN) - Bear of the Day - Zacks 02.14.12 | 01:02 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 02.08.12 | 09:02 am
- BioMarin's Facility Expansion Backed - Analyst Blog - Zacks 12.22.11 | 10:12 am
- Facility Expansion at BioMarin - Analyst Blog - Zacks 11.29.11 | 10:11 am
- Activist Hedge Fund Accipiter Capital's Top Stock Picks - Seeking Alpha 11.29.11 | 09:11 am
